Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Laure Michaud; Kurt Bantilan; Audrey Mauguen; Craig H. Moskowitz; Andrew D. Zelenetz; Heiko Schöder

doi:10.2967/jnumed.122.264740

Research ArticleClinical Investigation

Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz and Heiko Schöder

Journal of Nuclear Medicine April 2023, 64 (4) 536-541; DOI: https://doi.org/10.2967/jnumed.122.264740

Laure Michaud

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kurt Bantilan

2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Audrey Mauguen

3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Craig H. Moskowitz

4Department of Medicine, University of Miami Health System, Miami, Florida

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew D. Zelenetz

2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Heiko Schöder

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 4

April 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz, Heiko Schöder

Journal of Nuclear Medicine Apr 2023, 64 (4) 536-541; DOI: 10.2967/jnumed.122.264740

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz, Heiko Schöder

Journal of Nuclear Medicine Apr 2023, 64 (4) 536-541; DOI: 10.2967/jnumed.122.264740

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

International Metabolic Prognostic Index Is Superior to Other Metabolic Tumor Volume-Based Prognostication Methods in a Real-Life Cohort of Diffuse Large B-Cell Lymphoma
Validation of the {Delta}SUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial

Google Scholar

Keywords

18F-FDG PET/CT
diffuse large B-cell lymphoma
metabolic tumor volume
δ-SUVmax
Deauville score

Main menu

User menu

Search

Prognostic Value of ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords